Anthony Cousien
Anthony Cousien
INSERM U1137
Verified email at inserm.fr
Title
Cited by
Cited by
Year
Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study
K Champenois, A Cousien, L Cuzin, S Le Vu, S Deuffic-Burban, E Lanoy, ...
BMC infectious diseases 13 (1), 1-10, 2013
1012013
Hepatitis C treatment as prevention of viral transmission and liver‐related morbidity in persons who inject drugs
A Cousien, VC Tran, S Deuffic‐Burban, M Jauffret‐Roustide, JS Dhersin, ...
Hepatology 63 (4), 1090-1101, 2016
862016
How to optimize hepatitis C virus treatment impact on life years saved in resource‐constrained countries
D Obach, Y Yazdanpanah, G Esmat, A Avihingsanon, S Dewedar, ...
Hepatology 62 (1), 31-39, 2015
332015
Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis c virus–infected patients in a country with limited resources: The case of egypt
D Obach, S Deuffic-Burban, G Esmat, WA Anwar, S Dewedar, V Canva, ...
Clinical infectious diseases 58 (8), 1064-1071, 2014
302014
Risk factors for syphilis infection in men who have sex with men: results of a case–control study in Lille, France
K Champenois, A Cousien, B Ndiaye, Y Soukouna, V Baclet, I Alcaraz, ...
Sexually transmitted infections 89 (2), 128-132, 2013
292013
Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review
A Cousien, VC Tran, S Deuffic‐Burban, M Jauffret‐Roustide, JS Dhersin, ...
Journal of viral hepatitis 22 (3), 213-229, 2015
282015
The need for treatment scale-up to impact HCV transmission in people who inject drugs in Montréal, Canada: a modelling study
A Cousien, P Leclerc, C Morissette, J Bruneau, É Roy, VC Tran, ...
BMC infectious diseases 17 (1), 1-10, 2017
262017
Effectiveness and cost‐effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: the case of France
A Cousien, VC Tran, S Deuffic‐Burban, M Jauffret‐Roustide, G Mabileau, ...
Journal of viral hepatitis 25 (10), 1197-1207, 2018
212018
How modelling can enhance the analysis of imperfect epidemic data
S Cauchemez, N Hoze, A Cousien, B Nikolay
Trends in parasitology 35 (5), 369-379, 2019
172019
Effectiveness and cost-effectiveness of immediate vs. delayed treatment of HCV-infected patients in a country with limited resources: the case of Egypt
D Obach, S Deuffic-Burban, G Esmat, WA Anwar, S Dewedar, V Canva, ...
Clin Infect Dis 58 (8), 1064-71, 2014
122014
O89 Impact of new DAA-containing regimens on HCV transmission among injecting drug users (IDUs): a model-based analysis (ANRS 12376)
A Cousien, VC Tran, M Jauffret-Roustide, S Deuffic-Burban, JS Dhersin, ...
Journal of Hepatology 60 (1), S36-S37, 2014
72014
On computer‐intensive simulation and estimation methods for rare‐event analysis in epidemic models
S Clémençon, A Cousien, MD Felipe, VC Tran
Statistics in medicine 34 (28), 3696-3713, 2015
52015
Is expert opinion reliable when estimating transition probabilities? The case of HCV-related cirrhosis in Egypt
A Cousien, D Obach, S Deuffic-Burban, A Mostafa, G Esmat, V Canva, ...
BMC medical research methodology 14 (1), 1-9, 2014
42014
Assessing Zika Virus Transmission Within Households During an Outbreak in Martinique, 2015–2016
A Cousien, S Abel, A Monthieux, A Andronico, I Calmont, M Cervantes, ...
American journal of epidemiology 188 (7), 1389-1396, 2019
32019
An algorithm applied to national surveillance data for the early detection of major dengue outbreaks in Cambodia
J Ledien, K Souv, R Leang, R Huy, A Cousien, M Peas, Y Froehlich, ...
PloS one 14 (2), e0212003, 2019
32019
Non-parametric adaptive estimation of order 1 Sobol indices in stochastic models, with an application to Epidemiology
G Castellan, A Cousien, VC Tran
Electronic journal of statistics 14 (1), 50-81, 2020
22020
Hand hygiene improvement or antibiotic restriction to control the household transmission of extended-spectrum β-lactamase-producing Escherichia coli: a mathematical modelling study
L Kardaś-Słoma, Y Yazdanpanah, A Perozziello, JR Zahar, FX Lescure, ...
Antimicrobial Resistance & Infection Control 9 (1), 1-9, 2020
12020
Modélisation dynamique de la transmission du virus de l'hépatite C chez les utilisateurs de drogues injectables: efficacité et coût-efficacité des interventions de réduction …
A Cousien
Sorbonne Paris Cité, 2015
12015
885 IMMEDIATE vs. DELAYED TREATMENT IN GENOTYPE 4-HCV INFECTED PATIENTS IN A LIMITED RESOURCES COUNTRY: A COST-EFFECTIVENESS ANALYSIS IN EGYPT (ANRS 12215)
D Obach, S Deuffic-Burban, G Esmat, WA Anwar, S Dewedar, V Canva, ...
Journal of Hepatology 58, S364, 2013
12013
Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach
M Castry, A Cousien, V Supervie, A Velter, J Ghosn, AD Paltiel, ...
Gut, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20